11 – 20 of 96
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma–LuDO-N
- Contribution to journal › Article
-
Mark
The immune cell atlas of human neuroblastoma
- Contribution to journal › Article
-
Mark
Patient-associated mutations in Drosophila Alk perturb neuronal differentiation and promote survival
- Contribution to journal › Article
- 2021
-
Mark
Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma : What now?
- Contribution to journal › Article
-
Mark
Anti-tumor effects of rigosertib in high-risk neuroblastoma
- Contribution to journal › Article
-
Mark
Refinement of a differentiation protocol using neuroblastoma SH-SY5Y cells for use in neurotoxicology research
(2021) In Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 149. p.1-13
- Contribution to journal › Article
-
Mark
Microenvironmental Impact on Tumour Cell Phenotype and Genotype in Adult and Paediatric Tumours
(2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
- 2020
-
Mark
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
- Contribution to journal › Article
-
Mark
Discovery of epi-enprioline as a novel drug for the treatment of vincristine resistant neuroblastoma
- Contribution to journal › Article
-
Mark
Gene expression signature of acquired chemoresistance in neuroblastoma cells
- Contribution to journal › Article
